Clinical Trial Update: Effect of Inhaled Insulin (AERx® iDMS) on Blood Glucose Control in Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update for inhaled insulin (AERx iDMS) in type 2 diabetes; the study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• AERx iDMS (inhaled insulin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: TERMINATED